Skip to main content
. 2016 Jan 11;31(3):657–665. doi: 10.1093/humrep/dev329

Figure 2.

Figure 2

Participant outcomes for the EAGeR trial. Notes: (1) Information regarding outcomes for 10 women who originally withdrew from the study was obtained via chart abstraction and hCG testing of stored urine samples (eight implantation failures and two live births). (2) There are a total of 55 women with implantation failures: 34 from the original trial (including 3 second peri-conception losses and 31 women with a positive pregnancy test without ultrasound confirmation of which 5 withdrew following the loss) and 21 newly detected implantation failures based on hCG testing of stored urine samples. (3) There are a total of 133 women with a clinical losses (127 clinical losses, 6 ectopic pregnancies). Upon further chart review, four losses initially classified as ‘probable ectopic’ were reclassified as one ectopic, one embryonic, one pre-embryonic and one unknown; three previously unknown losses were classified as one ectopic, one embryonic, one fetal.